Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Axogen Inc

AXGN
6,76
-0,07 (-1,02%)
Ultimo aggiornamento: 16:49:04
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/5/202422:30GLOBEAxogen Processing Center (APC) Celebrates its Opening with..
16/5/202413:00GLOBEAxogen Inc. Initiates Rolling Submission of Biologics..
14/5/202413:00GLOBEAxogen, Inc to Participate at Leerink Partners Healthcare..
02/5/202413:00GLOBEAxogen, Inc Reports First Quarter 2024 Financial Results
29/4/202422:50GLOBEAxogen Announces First Surgical Implants of Avive+ Soft..
16/4/202413:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
08/3/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:38EDGAR2Form 8-K - Current report
08/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:18EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202414:53EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202414:45EDGAR2Form POS AM - Post-Effective amendments for registration..
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:29EDGAR2Form 8-K - Current report
05/3/202413:16EDGAR2Form 8-K - Current report
05/3/202413:00GLOBEAxogen, Inc Reports 2023 Fourth Quarter and Full-Year..
23/2/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202421:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:30GLOBEAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year..
12/2/202419:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:15GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
02/2/202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202423:00GLOBEAxogen, Inc. Announces Positive Topline Results from REPOSE,..
11/1/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/1/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202413:05EDGAR2Form 8-K - Current report
05/1/202423:21EDGAR2Form 8-K/A - Current report: [Amend]
04/1/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202422:56EDGAR2Form 8-K - Current report
04/1/202422:45GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
04/1/202422:40GLOBEAxogen Announces Plan for Leadership Transition with CEO..
04/1/202422:35GLOBEAxogen Announces Promotions on Research and Development Team
26/12/202322:21EDGAR2Form 8-K - Current report
26/12/202322:15GLOBEAxogen, Inc. Appoints Kathy Weiler to its Board of Directors
13/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:38EDGAR2Form 144 - Report of proposed sale of securities
06/12/202313:15EDGAR2Form 8-K - Current report
06/12/202313:00GLOBEAxogen Announces Transition of Finance Team Leadership
01/12/202323:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20/11/202313:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
07/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:13EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results
Apertura: 6,86 Min: 6,67 Max: 6,86
Chiusura: 6,83

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network